Molecular mechanisms underlying the interaction between ZD1839 (‘Iressa’) and cisplatin/5-fluorouracil

This publication has 31 references indexed in Scilit:

• Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF‐κB and AP‐1 activation and IL‐8 and VEGF expression in human head and neck squamous cell carcinoma lines
  International Journal of Cancer, 2002
• Time-Dependent Changes in Factors Involved in the Apoptotic Process in Human Ovarian Cancer Cells as a Response to Cisplatin
  Gynecologic Oncology, 2002
• Apoptosis: A Link between Cancer Genetics and Chemotherapy
  Published by Elsevier ,2002
• Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth
  Annals of Oncology, 2002
• The EGFR as a target for anticancer therapy—focus on cetuximab
  European Journal Of Cancer, 2001
• The EGFR family and its ligands in human cancer
  European Journal Of Cancer, 2001
• Glutathione-associated enzymes in head and neck squamous cell carcinoma and response to cisplatin-based neoadjuvant chemotherapy
  International Journal of Cancer, 2001
• Combined Modality Therapy of A431 Human Epidermoid Cancer Using Anti-EGFr Antibody C225 and Radiation
  Cancer Biotherapy & Radiopharmaceuticals, 1999
• Cellular and molecular determinants of cisplatin resistance
  European Journal Of Cancer, 1998
• Antitumor Effects of Doxorubicin in Combination With Anti-epidermal Growth Factor Receptor Monoclonal Antibodies
  JNCI Journal of the National Cancer Institute, 1993